https://www.selleckchem.com/pr....oducts/nutlin-3a.htm
05). Furthermore, the rates of cardiac transplantation and device explantation were also similar (all P .05). Unadjusted survival was comparable between the groups at 30-days, 90-days, and 1-year following LVAD implantation (all P .05). In addition, lower prealbumin did not impact risk-adjusted 1-year mortality when modeled either as a categorical (OR, 1.08; 95% CI, 0.48-2.12; P = .82) or continuous variable (OR, 1.99; 95% CI, 0.73-2.34; P = .96). CONCLUSIONS This study demonstrates that lower prealbumin levels were not pred